Annovis Bio
ANVS
30 hedge funds and large institutions have $10.6M invested in Annovis Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
7% more funds holding
Funds holding: 28 → 30 (+2)
1.85% less ownership
Funds ownership: 14.19% → 12.34% (-1.9%)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
42% less capital invested
Capital invested by funds: $18.3M → $10.6M (-$7.74M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.71M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$80.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.3K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$4.58M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$1.14M |
| 3 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$145K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$33K |
| 5 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
-$14.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WWP
26
WR Wealth Planners
Columbia,
Missouri
| $1.42K | – | – | – |
|
|
CAS
27
Coppell Advisory Solutions
Coppell,
Texas
| $998 | -$2.15K | -174 | -94% |
|
28
UBS Group
Zurich,
Switzerland
| $949 | – | – | – |
|
29
Qube Research & Technologies (QRT)
London,
United Kingdom
| $19 | +$25 | +2 | New |
|
|
LCM
30
Lynwood Capital Management
Toronto,
Ontario, Canada
| – | -$145K | -10,131 | Closed |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.11K | -90 | -69% |
|
ANVS Hedge Fund Activity: Q3 2023 in Review
30 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2023, worth a combined $10.6M — down 42% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ANVS positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $3.71M. The largest seller was AIGH Capital Management, cutting an estimated $4.58M.
- 30 institutional investors held Annovis Bio (ANVS) as of Q3 2023, up from 28 in Q2 2023.
- Funds reported $10.6M of Annovis Bio stock for Q3 2023, down 42% quarter-over-quarter.
- 3 funds opened new Annovis Bio positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Annovis Bio buyer in Q3 2023 was Adage Capital Partners, an estimated $3.71M added.
- The largest Annovis Bio seller in Q3 2023 was AIGH Capital Management, an estimated $4.58M sold.
Based on aggregated 13F filings for Q3 2023.